Skip to main content

Table 2 Laboratory characteristics of the studied patients

From: The impact of long non-coding RNA H19 on metabolic features and reproductive phenotypes of Egyptian women with polycystic ovary syndrome

 

Control group (mean ± SD) (n = 50)

PCOS group (mean ± SD) (n = 50)

P

Total cholesterol (mg/dL)

126.7 ± 20.65

199.9 ± 12.17

 < 0.001*

Triglycerides (mg/dL)

139.6 ± 11.19

240.5 ± 91.46

 < 0.001*

LDL cholesterol (mg/dL)

105.8 ± 4.32

152.7 ± 13.77

 < 0.001*

HDL cholesterol (mg/dL)

52.26 ± 4.44

34.76 ± 4.1

 < 0.001*

Fasting plasma glucose (mg/dL)

75.12 ± 8.95

94.11 ± 6.81

 < 0.001*

Fasting serum insulin (lU/mL)

6.85 ± 1.45

16.1 ± 7.41

 < 0.001*

HbA1c (%)

4.77 ± 0.147

5.9 ± 0.12

 < 0.001*

HOMA-IR

1.4 ± 0.85

4.63 ± 2.12

 < 0.001*

HOMA β

164.5 ± 22.1

196.8 ± 31.11

 < 0.001*

FSH (mIU/mL)

5.89 ± 1.01

5.06 ± 1.49

 < 0.05*

LH (mIU/mL)

3.54 ± 1.22

5.439 ± 1.5

 < 0.001*

LH/FSH

0.53 ± 0.030

1.15 ± 0.18

 < 0.001*

AMH (ng/ml)

2.54 ± 0.4

5.339 ± 0.61

 < 0.001*

DHEA-S (mg/mL)

0.92 ± 0.48

1.45 ± 0.84

 < 0.001*

Total testosterone (ng/mL)

0.51 ± 0.15

1.53 ± 0.13

 < 0.001*

  1. HOMA-IR Homeostasis model assessments of insulin resistance, DHEA Dehydroepiandrosterone
  2. *Statistically significant (P < 0.05)